Yellow fever vaccine (YFV) immunization coverage among 1-year olds in Cameroon
Cameroon: Yellow fever vaccine (YFV) immunization coverage among 1-year olds was 75.0% in 2025. ▲ Rising
Yellow fever vaccine (YFV) immunization coverage among 1-year olds in Cameroon, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Cameroon recorded 75.0% for yellow fever vaccine (yfv) immunization coverage among 1-year olds in 2025.
That represents a change of up 5.6% on the previous year and up 8.7% over ten years.
Over the whole period, yellow fever vaccine (yfv) immunization coverage among 1-year olds in Cameroon peaked at 79.0% in 2010 and was at its lowest, 0.0%, in 2000.
That places Cameroon 16th out of 45 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently rising across the 26 years of available data.
Yellow fever vaccine (YFV) immunization coverage among 1-year olds in Cameroon, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 59.0% | — |
| 2005 | 68.0% | +15.3% |
| 2006 | 72.0% | +5.9% |
| 2007 | 74.0% | +2.8% |
| 2008 | 77.0% | +4.1% |
| 2009 | 72.0% | -6.5% |
| 2010 | 79.0% | +9.7% |
| 2011 | 76.0% | -3.8% |
| 2012 | 74.0% | -2.6% |
| 2013 | 71.0% | -4.1% |
| 2014 | 70.0% | -1.4% |
| 2015 | 69.0% | -1.4% |
| 2016 | 72.0% | +4.3% |
| 2017 | 68.0% | -5.6% |
| 2018 | 64.0% | -5.9% |
| 2019 | 62.0% | -3.1% |
| 2020 | 62.0% | +0.0% |
| 2021 | 61.0% | -1.6% |
| 2022 | 64.0% | +4.9% |
| 2023 | 67.0% | +4.7% |
| 2024 | 71.0% | +6.0% |
| 2025 | 75.0% | +5.6% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 42.2% | 0.0% | 77.0% | 10 |
| 2010s | 70.5% | 62.0% | 79.0% | 10 |
| 2020s | 66.7% | 61.0% | 75.0% | 6 |
Countries ranked near Cameroon
More health data for Cameroon
- Un projection of annual infant deaths, annual growth rate -1.28 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.7821 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 786.1 deaths per 1,000 people (2090)
- Number of infants who die before age 1 12,841 deaths (2100)
- Population ages 75-79, female, annual growth rate 1.81 % change on previous year (2025)
- Population ages 75-79, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, female, per capita 0.0026 units per person (2025)
- Population ages 75-79, male, annual growth rate 1.95 % change on previous year (2025)
- Population ages 75-79, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 75-79, male, per capita 0.002 units per person (2025)
Frequently asked questions
- What is yellow fever vaccine (yfv) immunization coverage among 1-year olds in Cameroon?
- Yellow fever vaccine (yfv) immunization coverage among 1-year olds in Cameroon was 75.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest yellow fever vaccine (yfv) immunization coverage among 1-year olds recorded in Cameroon?
- The highest recorded value was 79.0% in 2010.
- What is the lowest yellow fever vaccine (yfv) immunization coverage among 1-year olds recorded in Cameroon?
- The lowest recorded value was 0.0% in 2000.
- How does Cameroon rank for yellow fever vaccine (yfv) immunization coverage among 1-year olds?
- Cameroon ranks 16th out of 45 countries with data for 2025.
- Is yellow fever vaccine (yfv) immunization coverage among 1-year olds rising or falling in Cameroon?
- Over the last ten years it is up 8.7%. The long-run trend across the full record is rising.
- Where does this Cameroon data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Yellow fever vaccine (YFV) immunization coverage among 1-year olds (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).